Structural Brain Connectivity and Treatment Improvement in Mood Disorder

Sébastien Dam,Jean-Marie Batail,Gabriel H Robert,Dominique Drapier,Pierre Maurel,Julie Coloigner

2024-03-22

Abstract:Background: The treatment of depressive episodes is well established, with clearly demonstrated effectiveness of antidepressants and psychotherapies. However, more than one-third of depressed patients do not respond to treatment. Identifying the brain structural basis of treatment-resistant depression could prevent useless pharmacological prescriptions,adverse events, and lost therapeutic opportunities.Methods: Using diffusion magnetic resonance imaging, we performed structural connectivity analyses on a cohort of 154 patients with mood disorder (MD) -- and 77 sex- and age-matched healthy control (HC) participants. To assess illness improvement, the MD patients went through two clinical interviews at baseline and at 6-month follow-up and were classified based on the Clinical Global Impression-Improvement score into improved or not-improved. First, the threshold-free network-based statistics was conducted to measure the differences in regional network architecture. Second, nonparametric permutations tests were performed on topological metrics based on graph theory to examine differences in connectome organization. Results: The threshold-free network-based statistics revealed impaired connections involvingregions of the basal ganglia in MD patients compared to HC. Significant increase of local efficiency and clustering coefficient was found in the lingual gyrus, insula and amygdala in the MD group. Compared with the not-improved, the improved displayed significantly reduced network integration and segregation, predominately in the default-mode regions, including the precuneus, middle temporal lobe and rostral anterior cingulate.Conclusions: This study highlights the involvement of regions belonging to the basal ganglia, the fronto-limbic network and the default mode network, leading to a better understanding of MD disease and its unfavorable outcome.

Neurons and Cognition

What problem does this paper attempt to address?

This paper aims to explore the relationship between brain structural connectivity and treatment outcome improvement in patients with Mood Disorder (MD) and attempts to identify the structural basis of the brain in treatment-resistant depression patients. Through these studies, the authors hope to predict in clinical practice which patients may be insensitive to conventional drug treatments in advance, thereby avoiding ineffective prescriptions, adverse reactions, and missed opportunities for other treatments.

To achieve this goal, researchers used Diffusion Magnetic Resonance Imaging (dMRI) to analyze the structural connectivity of 154 MD patients and 77 age- and gender-matched healthy controls. By conducting clinical assessments at baseline and 6-month follow-up, MD patients were divided into "improved" and "non-improved" groups. The study employed Threshold-Free Network-Based Statistics (TFNBS) to measure differences in regional network architecture and used graph theory-based methods for non-parametric permutation testing of connectivity group organization.

The results showed impaired connectivity in the basal ganglia region among MD patients; in the MD group, the local efficiency and clustering coefficient of the lingual gyrus, insula, and amygdala were significantly increased. In contrast, the "improved" group showed a significant reduction in network integration and segregation in the default mode network regions (including the precuneus, middle temporal gyrus, and anterior cingulate cortex) compared to the "non-improved" group.

In summary, this study highlights the role of specific regions in the basal ganglia, frontal-limbic system, and default mode network in MD and its adverse outcomes, providing important clues for further understanding of MD.